Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-tuberculous mycobacteria (NTM) are a diverse group of bacteria within the genus *Mycobacterium* that do not cause tuberculosis (*Mycobacterium tuberculosis*) or leprosy (*Mycobacterium leprae*). NTM are ubiquitous in the environment and can cause a range of infections, particularly in individuals with pre-existing lung conditions or weakened immune systems. Treatment is challenging due to antibiotic resistance and requires prolonged multi-drug regimens.
Antibiotic mechanisms vary depending on the drug; target bacterial cell wall synthesis, protein synthesis, or DNA replication.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-tuberculous Mycobacteria (NTM).